Document is current
Any future updates will be listed below
-
Authors
Hsieh, Chang-Yu
Chen, Po-Hua
Huang, Chang-Ming
Tsai, Tsen-Fang
- License Information
-
More Information
Article History
Received: 25 December 2023
Revised: 19 January 2024
Accepted: 26 April 2024
First Online: 1 June 2024
Declarations
:
: Tsen-Fang Tsai has conducted clinical trials or received honoraria for serving as a consultant for Abbvie, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli-Lilly, Galderma, Janssen-Cilag, Merck Sharp & Dohme, Novartis International AG, Pfizer Inc., and UCB Pharma.Chang-Yu Hsieh received honoraria for educational events from Boehringer Ingelheim.Po-Hua Chen and Chang-Ming Huang have nothing to declare.
: This study was approved by the Institutional Review Board (IRB) of National Taiwan University Hospital (202308112RINB).
